Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Coronavirus vaccine: Did Pfizer put profit first? | DW News |

Last year, Albert Bourla had a choice and he decided to take a massive risk. The CEO of the pharmaceutical giant Pfizer could have made it easy for himself by accepting billions of and participating in Operation Warp Speed, the US government's initiative to create multiple vaccines as fast as possible.

But he preferred to remain independent.
Bourla decided to invest $2 billion (€1.6 billion) in BioNTech, a startup company in western Germany. His instinct was right: BioNTech came up with the formula for the first COVID-19 vaccine to be approved by the United States, EU and other governments. By the end of the year, Pfizer had produced 50 million doses of BioNTech's COVID-19 mRNA vaccine, BNT162b2. The goal for 2021 is to produce more than a billion doses.

BioNTech-Pfizer originally demanded €54 per vaccine dose

by Oui on Sun Feb 21st, 2021 at 03:17:47 PM EST

Display:

Occasional Series